Good evening :)

How to use scorecard? Learn more

AMC Logo

HDFC Pharma and Healthcare Fund Direct Growth

Growth
22.541.51% (+0.34)
High
Low
Returns
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

Mid-size Fund

Assets Under Mgmt: ₹ 3,310 Cr

Very High Risk

Principle investment will be at very high risk

Scorecard

Performance

Avg

Return has been average, nothing exciting vs others

Risk

High

Stay alerted, risk is higher vs others

Cost

High

Higher costs on pocket vs others

Composition

Avg

Average allocation strategy, nothing exciting

Red flags

Low

We got you covered, no major red flags identified

How to use scorecard? Learn more

Mid-size Fund

Assets Under Mgmt: ₹ 3,310 Cr

Very High Risk

Principle investment will be at very high risk

HDFC Pharma and Healthcare Fund Performance & Key Metrics

HDFC Pharma and Healthcare Fund Performance & Key Metrics

No LabelNo LabelExpense RatioExpense RatioNo LabelNo Label
1.080.721.47
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.740.2151.76

HDFC Pharma and Healthcare Fund Scheme InfoHDFC Pharma and Healthcare Fund Scheme Info

PlanPlanLock inLock in
Lock in Period

Period before which your investment can't be withdrawn from the MF scheme

Exit LoadExit Load
Exit Load

The fee that the AMC charges investors at the time of exiting or redeeming their fund units.

Growth0 yrs1.00%
1% on or before 30D Nil after 30D
SIP Inv.SIP Inv.
Sip Investment

If SIP investments are allowed in the fund or not

Min. LumpsumMin. Lumpsum
Minimum Lumpsum Inv Amount

Minimum investment the AMC allows in the given scheme via lumpsum route

Allowed₹ 100
Initial: ₹ 100 Incremental: ₹ 100
BenchmarkBenchmark
Benchmark Index

Benchmark index wrt which performance of the fund is tracked

BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

HDFC Pharma and Healthcare Fund Peers

HDFC Pharma and Healthcare Fund Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care
Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
HDFC Pharma and Healthcare Fund26.73%31.81%
Nippon India Pharma Fund10.35%18.01%17.51%
ICICI Pru Healthcare Fund6.30%21.61%20.68%
SBI Healthcare Opp Fund20.84%24.00%18.27%

HDFC Pharma and Healthcare Fund Returns Comparison

Compare HDFC Pharma and Healthcare Fund with any MF, ETF, stock or index
Compare HDFC Pharma and Healthcare Fund with any MF, ETF, stock or index
HDFC Pharma and Healthcare Fund
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

HDFC Pharma and Healthcare Fund Portfolio

HDFC Pharma and Healthcare Fund Asset Allocation

HDFC Pharma and Healthcare Fund Asset Allocation

Actual

Target

Dec 2025

Mar 2026

Jun 2026

Aug 2026

ACTUAL
Cash & EquivalentsEquity1.58%98.42%

Dec 2025

Mar 2026

Jun 2026

Aug 2026

Tickertape Separator

HDFC Pharma and Healthcare Fund Sector Distribution

HDFC Pharma and Healthcare Fund Sector Distribution

+1 moreCommodities TradingMiscellaneousHealth Care Equipment & SuppliesLabs & Life Sciences ServicesPharmaceuticals-0.25 %0.47 %1.83 %2.15 %24.15 %71.65 %

Dec 2025

Mar 2026

Jun 2026

Aug 2026

Tickertape Separator

HDFC Pharma and Healthcare Fund Sector Weightage

HDFC Pharma and Healthcare Fund Sector Weightage

Jun 25Sep 25Dec 25Mar 26Jun 26Aug 2676.66%77.10%72.45%70.54%69.64%71.65%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

HDFC Pharma and Healthcare Fund Current Holdings

HDFC Pharma and Healthcare Fund Current Holdings

Equity

Others

Sort holdings
  • Constituent
    Holding Weight
    3M Change

AMC Profile of HDFC Pharma and Healthcare Fund

AMC Profile of HDFC Pharma and Healthcare Fund

HDFC Asset Management Company, investment manager to HDFC Mutual Fund, is one of the leading AMCs in the country. The company operates as a joint venture between Housing Development Finance Corporation (HDFC) and Standard Life Investments (SLI).

HDFC Asset Management Company, investment manager to HDFC Mutual Fund, is one of the leading AMCs in the country. The company operates as a joint venture between Housing Development Finance Corporation (HDFC) and Standard Life Investments (SLI).

  • No.of Schemes

    90

  • Total AUM

    ₹ 9,63,245.27 Cr.

HDFC Pharma and Healthcare Fund Manager Details

HDFC Pharma and Healthcare Fund Manager Details

HDFC Pharma and Healthcare Fund Manager Profile

HDFC Pharma and Healthcare Fund Manager Profile

Qualification

PGDM - IMT, B.E. (Civil), CFA (USA)

Past Experience

Over 7 years of experience in equity research and 2 years in financial advisory.

Funds Managed (2)
1Y Returns
0.22%
0.22%
3Y CAGR
7.04%
7.04%
Base Exp. Ratio
1.18%
1.18%
1Y Returns
26.73%
26.73%
3Y CAGR
Base Exp. Ratio
0.72%
0.72%

HDFC Pharma and Healthcare Fund Manager Performance (0)

HDFC Pharma and Healthcare Fund Manager Performance (0)

Loading...

HDFC Pharma and Healthcare Fund Review & Opinions

HDFC Pharma and Healthcare Fund Review & Opinions

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.

Frequently asked questions

Frequently asked questions

  1. The current NAV of HDFC Pharma and Healthcare Fund is ₹22.54, as of 17th September 2026.

  2. The HDFC Pharma and Healthcare Fund was launched on 4th October 2023. This mutual fund's past returns are as follows:
    • 1 Year Returns: 26.73%

  3. The top sectors HDFC Pharma and Healthcare Fund has invested in are as follows:
    • Pharmaceuticals | 71.65%
    • Labs & Life Sciences Services | 24.15%
    • Health Care Equipment & Supplies | 2.15%
    • Miscellaneous | 1.83%
    • Commodities Trading | 0.47%
    This data is as on 17th September 2026.

  4. The top 5 holdings for HDFC Pharma and Healthcare Fund are as follows:
    • Divi's Laboratories Ltd | 9.54%
    • Sun Pharmaceutical Industries Ltd | 8.94%
    • Torrent Pharmaceuticals Ltd | 4.08%
    • Max Healthcare Institute Limited | 4.06%
    • Lupin Limited | 4.04%
    This data is as on 17th September 2026.

  5. The asset allocation for HDFC Pharma and Healthcare Fund is as follows:
    • Equity | 98.42%
    • Cash & Equivalents | 1.58%
    This data is as on 17th September 2026.

  6. The AUM (i.e. assets under management) of HDFC Pharma and Healthcare Fund is ₹3310.64 Cr as of 17th September 2026.

  7. The expense ratio of HDFC Pharma and Healthcare Fund Plan is 0.72 as of 17th September 2026.

  8. The alpha ratio for the HDFC Pharma and Healthcare Fund is 10.80

    Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

  9. The volatility or standard deviation for the HDFC Pharma and Healthcare Fund is 13.08

    Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

  10. The Sharpe ratio for the HDFC Pharma and Healthcare Fund is 1.47

    The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

  11. The Sortino Ratio for the HDFC Pharma and Healthcare Fund is 0.16

    The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.

  12. The PE ratio of HDFC Pharma and Healthcare Fund is 51.76, while category PE ratio is 47.73.